https://www.selleckchem.com/pr....oducts/elacridar-gf1
0%(14/70 patients) vs 6.1% (6/98 patients), P = .006). The average energy IVS infusion per day was similar between the groups. This is the first study to demonstrate that AD use correlates with higher IVS volume rather than energy requirements in HPN patients, suggesting that high IVS volume requirements may be better associated with the patient's disease burden. Early and tailored mental health intervention may be beneficial in those with high IVS volume requirements. This is the first study to demonstrate that AD use correl
Curtir
Comentario
Compartilhar
